Stockholders’ Equity |
12 Months Ended |
|---|---|
Sep. 29, 2024 | |
| Equity [Abstract] | |
| Stockholders’ Equity |
Note 12 — Stockholders’ Equity
Dividends
There were no dividends declared or paid during the twelve months ended September 29, 2024 and October 1, 2023.
Common stock
During the twelve months ended September 29, 2024, there were 110,868 common shares issued to officers and employees, net of tax withholding of $245 thousand, in settlement of 13,000 vested restricted stock units, and 135,000 vested performance shares.
During the twelve months ended October 1, 2023, there were 46,432 common shares issued to officers, net of tax withholding of $58 thousand, in settlement of 66,000 restricted stock units which vested on January 1, 2023.
During the twelve months ended October 1, 2023, there were 40,000 unvested restricted shares cancelled on the departure of a board member and 40,000 unvested restricted shares granted to a newly elected board member.
On September 22, 2021 the Company announced authorization for a $1 million stock repurchase program. The shares authorized to be repurchased under the repurchase program may be purchased from time to time at prevailing market prices, through open market or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC.
During the twelve months ended September 29, 2024 and October 1, 2023, there were no common shares repurchased through the program.
As of September 29, 2024, and October 1, 2023, the total outstanding common shares were 6,873,938 and 6,763,070, respectively.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|